Rajen Mody
University of Michigan(US)Michigan United(US)Michigan Medicine(US)C. S. Mott Children's Hospital(US)
Publications by Year
Research Areas
Glioma Diagnosis and Treatment, Cancer, Hypoxia, and Metabolism, ATP Synthase and ATPases Research, Neuroblastoma Research and Treatments, Cancer Genomics and Diagnostics
Most-Cited Works
- → Integrative clinical genomics of metastatic cancer(2017)918 cited
- → Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth(2015)411 cited
- → Twenty-five–year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study(2008)384 cited
- → Irinotecan–temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial(2017)270 cited
- → XIAP deficiency: a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease(2010)260 cited
- → Irinotecan, Temozolomide, and Dinutuximab With GM-CSF in Children With Refractory or Relapsed Neuroblastoma: A Report From the Children’s Oncology Group(2020)